Standout Papers

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate ... 2001 2026 2009 2017 566
  1. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD (2001)
    Bengt Winblad, Knut Engedal et al. Neurology

Immediate Impact

4 from Science/Nature 69 standout
Sub-graph 1 of 21

Citing Papers

Donanemab in Early Alzheimer’s Disease
2021 Standout
Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis
2021 Standout
11 intermediate papers

Works of Anders Haglund being referenced

Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study
2006
An Economic Evaluation of Donepezil in Mild to Moderate Alzheimer’s Disease: Results of a 1-Year, Double-Blind, Randomized Trial
2002
and 1 more

Author Peers

Author Last Decade Papers Cites
Anders Haglund 666 499 73 302 18 1.2k
Sharon L. Rogers 704 677 80 370 8 1.5k
Neda Minakaran 370 273 47 321 19 1.1k
A.-L. Wetterholm 644 482 14 296 7 1.1k
Carina Wattmo 688 250 43 465 44 1.1k
C. Beck 994 213 53 560 10 1.6k
S. Gracon 432 394 27 382 11 1.0k
Ponni Subbiah 1013 738 11 414 18 1.6k
Lea T. Drye 914 401 50 376 45 1.7k
Lynda Booker 304 257 135 289 23 1.6k
M. Saleem Ismail 694 167 33 301 9 1.1k

All Works

Loading papers...

Rankless by CCL
2026